Related Experiment Videos
Development and utilization of physiologically based pharmacokinetic models for toxicological applications
1Union Carbide Chemicals and Plastics Company, Inc., Health, Safety, & Environmental Affairs, Danbury, Connecticut.
Journal of Toxicology and Environmental Health
|March 1, 1991
Summary
Physiologically based pharmacokinetic (PB-PK) modeling advances toxicological evaluations and chemical risk assessment by enabling tissue dosimetry extrapolation. This review details PB-PK model development, applications, and limitations for environmental chemicals.
Area of Science:
- Toxicology
- Pharmacokinetics
- Computational Modeling
Background:
- Physiologically based pharmacokinetic (PB-PK) modeling offers advanced methods for toxicological problem evaluation.
- PB-PK models facilitate tissue dosimetry extrapolation, enhancing their use in chemical risk assessment.
Purpose of the Study:
- To review the development and application of PB-PK modeling in toxicology.
- To compare PB-PK modeling with conventional compartmental analysis.
- To outline the construction, data requirements, and limitations of PB-PK models.
Main Methods:
- Literature review of PB-PK modeling development for toxicological applications.
- Comparison of fundamental differences between compartmental analysis and PB-PK modeling.
- Description of PB-PK model theory, principles, data acquisition, and construction steps.
Main Results:
- A comprehensive list of developed PB-PK models for environmental chemicals is provided.
- Illustrative examples showcase salient applications of PB-PK modeling in toxicology.
- Discussion of uncertainties and limitations inherent in PB-PK modeling.
Conclusions:
- PB-PK modeling is a valuable tool for toxicological assessment and chemical risk evaluation.
- Understanding the methodologies and limitations of PB-PK models is crucial for accurate application.
- Continued development and application of PB-PK models are expected to advance environmental health and safety.